Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Sep 30 · below the Ichimoku cloud · RSI 45 · MACD below its signal
None of the 29 investors followed here reported a position in SONA.CN in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SONA.CN trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for SONA.CN.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -11.1 | -1.2 | -21.5 | -3.2 | 1.7 | -1.6 | -6.7 | 23.2 | -13.0 | 6.7 | −28.9% | ||
| 2025 | 3.8 | 14.8 | -6.5 | 1.7 | 27.1 | 38.7 | 13.5 | 8.5 | -10.9 | 8.8 | -17.7 | -11.8 | +73.1% |
| 2024 | 25.0 | 1.7 | 47.5 | -20.0 | -2.8 | -15.7 | -6.8 | 1.8 | -3.6 | 0.0 | -7.4 | 4.0 | +8.3% |
| 2023 | 37.5 | 109.1 | -26.1 | 0.0 | 29.4 | 27.3 | -21.4 | -13.6 | 0.0 | -7.9 | 17.1 | 17.1 | +200.0% |
| 2022 | -13.6 | -7.9 | -28.6 | 0.0 | -66.0 | -5.9 | 18.8 | 0.0 | 0.0 | 52.6 | -24.1 | -27.3 | −81.8% |
| 2021 | -47.8 | -1.0 | -7.9 | 0.0 | -18.9 | -75.4 | 5.7 | -8.1 | -16.2 | 15.8 | 36.4 | -2.2 | −88.0% |
| 2020 | -4.0 | 408.3 | 77.0 | 75.0 | 48.1 | 11.8 | 361.7 | -51.1 | 6.8 | -53.2 | -69.1 | 237.6 | +2844.0% |
| 2019 | 16.0 | 13.8 | -9.1 | -6.7 | 0.0 | -10.7 | -16.0 | 4.8 | -4.5 | -9.5 | -31.6 | -3.8 | −50.0% |
| 2018 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 860.0 | -4.2 | 8.7 | +900.0% |
| 2017 | 0.0 | 0.0 | 0.0 | 0.0 | -33.3 | 0.0 | -25.0 | 33.3 | 25.0 | 0.0 | 0.0 | 0.0 | −16.7% |
| 2016 | 0.0 | 25.0 | -20.0 | 50.0 | 0.0 | 33.3 | -37.5 | 0.0 | 0.0 | 0.0 | 20.0 | 0.0 | +50.0% |
| 2015 | -12.5 | 14.3 | -37.5 | 20.0 | 0.0 | 33.3 | -12.5 | -28.6 | -40.0 | 33.3 | 0.0 | 0.0 | −50.0% |
| 2014 | 28.6 | 0.0 | 0.0 | 33.3 | -16.7 | 50.0 | -20.0 | 8.3 | -7.7 | -33.3 | -12.5 | 14.3 | +14.3% |
| 2013 | -11.1 | -6.2 | -13.3 | -7.7 | -41.7 | -14.3 | 0.0 | 150.0 | -26.7 | 27.3 | -21.4 | -36.4 | −61.1% |
| 2012 | -8.3 | -25.0 | -18.2 | -29.6 | 5.3 | -5.0 | -36.8 | 25.0 | 33.3 | 0.0 | -5.0 | -5.3 | −62.5% |
| 2011 | -13.2 | 21.7 | 0.0 | 0.0 | 7.1 | 13.3 | 14.7 | -17.9 | -25.0 | 8.3 | -11.5 | 4.3 | −9.4% |
| 2010 | 17.9 | -21.7 | -16.7 | 3.3 | 6.5 | -21.2 | 3.8 | 29.6 | 25.7 | -9.1 | 35.0 | -1.9 | +35.9% |
| 2009 | 14.3 | -31.2 | 18.2 | 0.0 | 115.4 | -42.9 | 37.5 | 254.5 | -48.7 | 20.0 | -6.3 | -13.3 | +178.6% |
| 2008 | -22.0 | 1.1 | -7.5 | -7.0 | 0.0 | -22.5 | -19.4 | -28.0 | -50.0 | -38.9 | -40.9 | 7.7 | −94.1% |
| 2007 | 49.2 | -16.2 | -12.5 | 10.7 | 3.2 | -3.1 | -14.8 | -16.7 | 12.7 | 21.0 | -35.3 | 21.6 | −7.8% |
No analyst coverage for this instrument.
Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing. It also engages in the development of targeted hyperthermia therapy, a photo thermal therapy for the treatment of cancer tumors; and diagnostic tools comprising lateral flow assay rapid and bovine tuberculosis tests. The company was founded in 2013 and is based in Halifax, Canada.
No recent headlines.